LABEST 2022: Emerging LA Biopharma Companies
https://tdg.ucla.edu/
Successful start-ups stake their roots in the Los Angeles region
Moderator: Hallie Kuhn
VP, Alexandria Venture Investments
Scott Foraker
CEO, A2 Bio
JJ Kang
CEO, Appia Bio
Brent Pfeiffenberger
COO, Neogene Therapeutics
Sumant Ramachandra, CEO, ImmPACT Bio
Видео LABEST 2022: Emerging LA Biopharma Companies канала UCLA TDG
Successful start-ups stake their roots in the Los Angeles region
Moderator: Hallie Kuhn
VP, Alexandria Venture Investments
Scott Foraker
CEO, A2 Bio
JJ Kang
CEO, Appia Bio
Brent Pfeiffenberger
COO, Neogene Therapeutics
Sumant Ramachandra, CEO, ImmPACT Bio
Видео LABEST 2022: Emerging LA Biopharma Companies канала UCLA TDG
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
How Kite, A Gilead Company, is Building a Global CAR T Franchise out of Los Angeles#UCLAMedTech2022 STRATEGIC INVESTORS PANEL: Opportunities and Trends in the Medtech IndustryMedTech Fast Pitch: VonovaUCLA MedTech 2021 Welcome VideoMade in LA: Case Studies in Bio SuccessLABEST 2021 - The Premier Bioscience and Biotech Conference in LA County (May 25 - 27)Slavica Tudzarova Inventor ProfileFDA as a Driver of Medical Device Innovation [UCLAMEDTECH 2021]#ProfessorSpotlights2022 Dr. Crystal Marconett #USC #LABEST2022Cutting Needle Holder: UCLA Stein Eye Institute - Maria Paula Quintero, Erin NaPier, Taras GoutKeynote Address by Director General Daren Tang, WIPOTransforming UCLA IP into Products - ZenomicsThe Economic Impact of COVID-19Feng Guo Inventor ProfileWelcome by Jessica Droge from AmgenDemo Track presenter, SpineX, at the 10th Annual UCLA MedTech Conference, 2022Virtual First Friday with Brian Bordley, Berkeley Skydeck FundTangible Research Property (TRP) Information - Steven Smale, Ph.D.Investing in Innovation: Oncology Webinar featuring University of Michigan, UCLA and YaleKeynote: Christopher Viehbacher CEO, BiogenUnitary Patent presented by Dr. Richard M Korn, Pearl Cohen